12.529MXN
4.04 BMXN
37.09 BMXN
181.34 M
About SWEDISH ORPHAN BIOVITRUM AB
Sector
CEO
Guido Oelkers
Headquarters
Solna
Website
Employees (FY)
1.77 K
Founded
2001
ISIN
SE0000872095
FIGI
BBG00YG44HC4
Swedish Orphan Biovitrum AB engages in the research, development, manufacture, and sale of pharmaceuticals. It operates through the Haematology, Immunology, and Specialty Care segments. The Haemotology segment focuses on haemophilia medicines Elocta and Alprolix. The immunology segment offers treatment for serious, disabling, and life-threatening diseases. The Specialty Care segment specializes in the treatment of genetic and metabolic diseases. The company was founded in 2001 and is headquartered in Solna, Sweden.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of SOBI/N is 541.907 MXN — it hasn't changed in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on BMV exchange SWEDISH ORPHAN BIOVITRUM AB stocks are traded under the ticker SOBI/N.
SWEDISH ORPHAN BIOVITRUM AB is going to release the next earnings report on Apr 25, 2024. Keep track of upcoming events with our Earnings Calendar.
SOBI/N stock is 0% volatile and has beta coefficient of 0.58. Check out the list of the most volatile stocks — is SWEDISH ORPHAN BIOVITRUM AB there?
One year price forecast for SWEDISH ORPHAN BIOVITRUM AB has a max estimate of 566.166 MXN and a min estimate of 436.100 MXN.
SOBI/N earnings for the last quarter are 0.86 MXN per share, whereas the estimation was 0.58 MXN resulting in a 46.77% surprise. The estimated earnings for the next quarter are 6.01 MXN per share. See more details about SWEDISH ORPHAN BIOVITRUM AB earnings.
SWEDISH ORPHAN BIOVITRUM AB revenue for the last quarter amounts to 8.22 B MXN despite the estimated figure of 7.23 B MXN. In the next quarter revenue is expected to reach 11.40 B MXN.
Yes, you can track SWEDISH ORPHAN BIOVITRUM AB financials in yearly and quarterly reports right on TradingView.
SOBI/N net income for the last quarter is 1.72 B MXN, while the quarter before that showed 149.43 M MXN of net income which accounts for 1.05 K% change. Track more SWEDISH ORPHAN BIOVITRUM AB financial stats to get the full picture.
Today SWEDISH ORPHAN BIOVITRUM AB has the market capitalization of 136.67 B, it has decreased by 0.95% over the last week.
No, SOBI/N doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, SOBI/N shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SWEDISH ORPHAN BIOVITRUM AB stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 20, 2024, the company has 1.77 K employees. See our rating of the largest employees — is SWEDISH ORPHAN BIOVITRUM AB on this list?
We've gathered analysts' opinions on SWEDISH ORPHAN BIOVITRUM AB future price: according to them, SOBI/N price has a max estimate of 566.17 MXN and a min estimate of 436.10 MXN. Read a more detailed SWEDISH ORPHAN BIOVITRUM AB forecast: see what analysts think of SWEDISH ORPHAN BIOVITRUM AB and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. SWEDISH ORPHAN BIOVITRUM AB EBITDA is 12.42 B MXN, and current EBITDA margin is 35.37%. See more stats in SWEDISH ORPHAN BIOVITRUM AB financial statements.